Aria Diagnostics Inc. said Tuesday it has raised $52.7 million in an oversubscribed Series C round of funding.
The San Jose-based molecular diagnostics company, formerly Tandem Diagnostics, said new investors included Palo Alto-based Meritech Capital Partners and an undisclosed mutual fund group. They were joined by existing investors Venrock, which has an office in Palo Alto, and Domain Associates.
No comments:
Post a Comment